U.S. Rep. Marjorie Taylor Greene, of Georgia, a vociferous critic of COVID-19 vaccine mandates, reported owning stock in three different COVID-19 vaccine makers during 2020, according to financial disclosures she submitted on Aug. 13.

The revelation was first reported by the Chattanooga Times Free Press newspaper.

For those of you wondering, the correct answer is D! Our current representative rails against the vaccine, but owns stock in 3 of the 4 major vaccine manufacturers. https://t.co/Zrxv39k3JQ

— Jennifer Strahan for Congress (@StrahanJennifer) December 18, 2021

Held Stock While Voting on COVID Bills

Green, a Republican who took office in 2020, held the investments in the companies as Congress was determining how best to manage pandemic relief efforts. Trillions of dollars were funneled into COVID relief bills in 2020 and 2021, including several billion to help drug companies develop, produce and distribute vaccines.

Greene owns stock in Pfizer, AstraZeneca, and Johnson & Johnson. According to the disclosure filed in August, her income from her stock in each of the three companies was between $201-$1,000.

Her assets in AstraZeneca are valued between $1,001-$15,000, while her assets in Pfizer and Johnson & Johnson are each valued between $15,001-$50,000, according to the disclosure.

Greene told a telephone town hall last month that she’s not vaccinated because “the government has no business to tell Americans that they should take the COVID vaccine or not,” CNN reported.

2022 GOP Opponent Alerted Media

The Times Free Press was alerted to Greene’s holdings by Jennifer Strahan, a Georgia businesswoman who announced her plans to run against Greene in the 2022 Republican primary.

Strahan posted a Twitter poll that asked readers to choose which of three vaccine companies Greene owns stock in, then left an option for “all of the above.”